The changes in C-peptide in the placebo group as compared with combination therapy indicate these increases or lack of decline are suggestive of a true effect of combination therapy and are not due to the ‘honeymoon phase’, a phase after type 1 diabetes diagnosis in which the pancreas is still able to produce insulin. This evidence concerns the gene INS and type 1 diabetes mellitus.